Welcome to our dedicated page for Nepra Foods news (Ticker: NPRFF), a resource for investors and traders seeking the latest updates and insights on Nepra Foods stock.
Nepra Foods Inc. (NPRFF) provides cutting-edge allergen-free and plant-based ingredient solutions for the global food industry. This news hub offers investors and industry professionals comprehensive access to official company updates, including financial disclosures, product innovation announcements, and strategic partnership developments.
Our curated collection features essential NPRFF updates spanning regulatory milestones, manufacturing advancements, and market expansion initiatives. Track the company's progress in hemp protein technology development, gluten-free formulation breakthroughs, and production facility optimizations through verified press releases and SEC filings.
Key updates include earnings reports detailing vertical integration benefits, announcements about proprietary blending techniques, and progress in sustainable food manufacturing practices. Users will find chronological updates on Nepra Foods' technical collaborations, quality control enhancements, and ingredient certification achievements.
Bookmark this page for streamlined access to NPRFF's evolving position in the specialty foods market. Check back regularly for factual updates on the company's scientific advancements and operational developments in allergen-free ingredient solutions.
Nepra Foods (OTCQB:NPRFF) has issued a clarification regarding its previous CEO letter, providing detailed financial figures for FY2025. The company reported revenue growth of 50.3% to CAD$6.25M and a 48.5% reduction in net losses to CAD$2.34M. Operating expenses decreased by 12.3% to CAD$3.62M, while lease liabilities were reduced by 29.9% to CAD$2.44M.
The company is undergoing board restructuring with active involvement from Chairman Mark Retzloff and board member Tim Hogan in daily operations. Nepra is pursuing accretive revenue streams alongside long-term R&D projects while maintaining focus on cost management and debt reduction initiatives.
Nepra Foods (NPRFF) CEO Billy Hogan has issued a shareholder letter highlighting significant financial improvements in fiscal year 2025. The company achieved a 50.3% increase in revenue while reducing net losses by 302%. Cost-cutting initiatives resulted in a 12.3% reduction in expenses and a 29.9% decrease in lease liabilities.
Management demonstrated commitment through personal sacrifices, with the CEO investing nearly $2 million and founders taking pay cuts. The company is restructuring its board of directors and focusing on creating additional revenue streams to support R&D projects. Under the leadership of CVO Chadwick White and Chairman Mark Retzloff, Nepra Foods is prioritizing profitability and shareholder value creation.
Nepra Foods (OTCQB:NPRFF) has completed the second and third tranches of its non-brokered private placement offering. The second tranche closed on September 2, 2025, raising US$76,660 through 1,277,667 units at US$0.06 per unit. The third tranche closed on September 10, 2025, raising US$146,341 through 2,439,024 units.
Each unit consists of one common share and one purchase warrant. The warrants allow holders to acquire additional shares at US$0.12 per share until September 2, 2027. The proceeds will be used for general working capital purposes. The securities are subject to a four-month hold period under Canadian securities laws.
Nepra Foods (OTCQB:NPRFF), a leader in gluten-free and plant-based protein solutions, reported strong Q1 2026 financial results with significant improvements across key metrics.
The company achieved revenue of CAD$1.82 million, marking a 39% increase year-over-year. Gross profit surged 141% to CAD$0.56 million, with margins expanding to 31% from 18% in the prior year. Net loss improved substantially, decreasing 60% to CAD$0.34 million. The growth was driven by new customer acquisition and increased starch product sales, while margin improvements resulted from reduced cost of sales and higher-margin blending services.
Nepra Foods (OTCQB:NPRFF), a plant-based and allergen-free food innovator, has filed its annual financial statements for FY2025 ended March 31. The company reported significant growth with revenue increasing 50% to C$6.25 million from C$4.16 million in FY2024.
Notable achievements include a remarkable Q4 2025 revenue surge of 203% to C$2.29 million and improved gross profit margins reaching 21.07% compared to 7.88% in the previous year. The management cease trade order (MCTO) issued by BCSC has been revoked following the successful filing of annual reports.
Nepra Foods (OTCQB:NPRFF) has received a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) due to a delay in filing its annual financial statements. The company has been granted an extension until September 29, 2025 to file its Annual Financial Filings for the period ended March 31, 2025.
Under the MCTO, the CEO and CFO are restricted from trading company securities until the filings are completed and the order is revoked. This order does not affect regular shareholders' ability to trade their securities. The company is actively working to complete the required filings before the extended deadline.
Nepra Foods (OTCQB:NPRFF) has announced a delay in filing its annual financial statements for the year ended March 31, 2025. The company missed the required filing deadline of July 29, 2025, as its auditors need additional time to complete their audit.
As a result, Nepra has received a management cease trade order affecting the CEO and CFO's ability to trade company securities. The company expects to file the Annual Filings by August 29, 2025, with a final deadline set for September 29, 2025. In the interim, Nepra will provide bi-weekly default status reports in accordance with National Policy 12-203.
[]Nepra Foods (OTCQB:NPRFF) has completed the first tranche of its non-brokered private placement, raising US$274,000 through the issuance of 4,566,667 units at US$0.06 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at US$0.12 per share until June 27, 2027.
The company expects to close a second tranche around July 11th, 2025. The proceeds will be used for general working capital purposes. The securities are subject to a four-month hold period ending October 26, 2025.